Repression of rpoS transcription by the cAMP-CRP complex.
A, in vitro transcription at the rpoS promoter Pp
in the presence of cAMP-CRP. The pRLG770
(24)-based plasmid carrying
the rpoS Pp (prpoS-Pp) was used for a template
for core RNAP, RpoD, and CRP derived from V. vulnificus (supplemental
Fig. 1). Produced 32P-labeled transcripts were separated on 6.5%
polyacrylamide/bisacrylamide (19:1), 7 m urea denaturing gel
showing two RNA bands (the control RNA of 108-nucleotide-long RNA-1 and the
210-nucleotide-long rpoS RNA) on each lane. Lane 1, pRLG770
(no rpoS promoter); lanes 2–6, prpoS-Pp
incubated with 0, 72, 144, 216, or 288 nm of CRP. B, in
vitro transcription at the rpoS promoter Pd in the
presence of cAMP-CRP. The pRLG770
(24)-based plasmid carrying
the rpoS Pd (prpoS-Pd) was used for an assay,
which resulted in production of RNA-1 and 188-nucleotide-long rpoS
RNA. Lane 1, pRLG770; lanes 2–6, prpoS-Pd
incubated with 0, 72, 144, 216, or 288 nm of CRP. C and
D, plots illustrating the relative intensity of rpoS
transcript. The intensities of two RNA bands on each lane, the 108-base RNA-1
transcript, and the longer transcript starting from one of the rpoS
promoters were estimated by densitometric reading (the plot C is from
A, and the plot D is from the B), and then each
rpoS transcript was normalized to RNA-1 on the same lane. Relative
intensity of the normalized rpoS transcript was indicated as the
percentage of that in the absence of CRP.